Related Experiment Video
Updated: Jun 7, 2026

Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
Published on: July 27, 2022
Probiotic yogurt effects on intestinal flora of patients with chronic liver disease
Jun-E Liu1, Yan Zhang, Jing Zhang
1School of Nursing, Capital Medical University, Beijing, China. liujune66@yahoo.com.cn
Background:
Patients with chronic liver disease generally have intestinal flora imbalance that is related to the development and worsening of the disease.
Objective:
The purpose of this study was to evaluate the effects of probiotic yogurt on intestinal flora of patients with chronic liver disease.
Methods:
A randomized controlled trial, pretest-posttest control group design, was used. Patients were randomized to an experimental group (41 patients) or a control group (40 patients). Patients in the experimental group were given probiotic yogurt (one cup each time, three times per day for 14 days) containing Bacillus bifidus, Lactobacillus acidophilus, Lactobacillus bulgaricus, and Streptococcus thermophilus within 2 hours after meals. Levels of fecal flora, symptoms and signs, and laboratory examination indexes were collected.
Results:
After intervention, the experimental group had a lower Escherichia coli count and reduced intestinal flora imbalance (p < .05). Comparison of the experimental and control groups after the intervention showed that the former had improved symptoms and signs, including significant improvement in debilitation, food intake, appetite, abdominal distension, and ascitic fluid (p < .05).
Conclusion:
Probiotic yogurt reduces the levels of intestinal flora imbalance and has an additional therapeutic effect on patients with chronic liver disease.
Related Concept Videos
Probiotics
Microbiota Modulation by Antibiotics
Dysbiosis of the Gut Microbiota
Bacterial Flora of the Large Intestine
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Microbiota of the Stomach and Small Intestine
